Drug Trial Radar · NCT01339091
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Last checked: Nov 19, 2026Latest source record: Jan 31, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
573
Actual
Start
Mar 2011
Primary completion
Sep 2012
Study completion Nov 2012
Sponsor
- Lead sponsor
- Durata Therapeutics Inc., an affiliate of Allergan plcIndustry
- Sponsor type
- Industry
- First posted
- Apr 20, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary object is to compare the early clinical efficacy (after 48-72 hours of therapy) of dalbavancin to the comparator regimen (vancomycin with the option to switch to oral linezolid) for the treatment of patients with a suspected or proven gram-positive bacterial skin or skin structure infection.
Conditions
- Abscess
- Wound Infection
- Surgical Site Infection
- Cellulitis
Interventions
DalbavancinDrug
IV Dalbavancin 1000 mg on Day 1 and 500 mg on Day 8
Vancomycin / LinezolidDrug
IV Vancomycin (1 gram Q 12 hours or 15mg/Kg Q 12 hours) with optional switch to oral linezolid (600 mg Q12 hours). Total duration of therapy is 10-14 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Early Clinical EfficacyTime frame: 48-72 hours after the initiation of study therapy
Locations
91 sites in 8 countries. Site status is shown where the registry gives one.
Durata Study Site
Anaheim, California
Durata Study Site
Azusa, California
Durata Study Site
Bellflower, California
Durata Study Site
Buena Park, California
Durata Study Site
Carmel, California
Durata Study Site
Chula Vista, California
Durata Study Site
Covina, California
Durata Study Site
Fountain Valley, California
Durata Study Site
La Mesa, California
Durata Study Site
Long Beach, California
Durata Study Site
Los Alamitos, California
Durata Study Site
Los Angeles, California
Durata Study Site
Oceanside, California
Durata Study Site
Palm Desert, California
Durata Study Site
Pasadena, California
Durata Study Site
Sacramento, California
Durata Study Site
San Diego, California
Durata Study Site
Santa Ana, California
Durata Study Site
Sylmar, California
Durata Study Site
Torrance, California
Durata Study Site
Upland, California
Durata Study Site
Whittier, California
Durata Study Site
Miami, Florida
Durata Study Site
Miami, Florida
Durata Study Site
Orlando, Florida
Durata Study Site
Saint Cloud, Florida
Durata Study Site
Tampa, Florida
Durata Study Site
Columbus, Georgia
Durata Study Site
Savannah, Georgia
Durata Study Site
Idaho Falls, Idaho
Durata Study Site
Pocatello, Idaho
Durata Study Site
Moline, Illinois
Durata Study Site
Rock Island, Illinois
Durata Study Site
Baton Rouge, Louisiana
Durata Study Site
Lafayette, Louisiana
Durata Clinical Site
New Orleans, Louisiana
Durata Study Site
Opelousas, Louisiana
Durata Study Site
Detroit, Michigan
Durata Study Site
Minneapolis, Minnesota
Durata Study Site
Las Vegas, Nevada
Showing 40 of 91 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.